Cargando…
Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19
The COVID-19 pandemic is a significant public health threat with unanswered questions regarding the immune system’s role in the disease’s severity level. Here, based on antibody kinetic data of severe and non-severe COVID-19 patients, topological data analysis (TDA) highlights that severity is not b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159681/ https://www.ncbi.nlm.nih.gov/pubmed/37149125 http://dx.doi.org/10.1016/j.mbs.2023.109011 |
_version_ | 1785037153471823872 |
---|---|
author | Blanco-Rodríguez, Rodolfo Ordoñez-Jiménez, Fernanda Almocera, Alexis Erich S. Chinney-Herrera, Gustavo Hernandez-Vargas, Esteban |
author_facet | Blanco-Rodríguez, Rodolfo Ordoñez-Jiménez, Fernanda Almocera, Alexis Erich S. Chinney-Herrera, Gustavo Hernandez-Vargas, Esteban |
author_sort | Blanco-Rodríguez, Rodolfo |
collection | PubMed |
description | The COVID-19 pandemic is a significant public health threat with unanswered questions regarding the immune system’s role in the disease’s severity level. Here, based on antibody kinetic data of severe and non-severe COVID-19 patients, topological data analysis (TDA) highlights that severity is not binary. However, there are differences in the shape of antibody responses that further classify COVID-19 patients into non-severe, severe, and intermediate cases of severity. Based on the results of TDA, different mathematical models were developed to represent the dynamics between the different severity groups. The best model was the one with the lowest average value of the Akaike Information Criterion for all groups of patients. Our results suggest that different immune mechanisms drive differences between the severity groups. Further inclusion of different components of the immune system will be central for a holistic way of tackling COVID-19. |
format | Online Article Text |
id | pubmed-10159681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101596812023-05-05 Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 Blanco-Rodríguez, Rodolfo Ordoñez-Jiménez, Fernanda Almocera, Alexis Erich S. Chinney-Herrera, Gustavo Hernandez-Vargas, Esteban Math Biosci Original Research Article The COVID-19 pandemic is a significant public health threat with unanswered questions regarding the immune system’s role in the disease’s severity level. Here, based on antibody kinetic data of severe and non-severe COVID-19 patients, topological data analysis (TDA) highlights that severity is not binary. However, there are differences in the shape of antibody responses that further classify COVID-19 patients into non-severe, severe, and intermediate cases of severity. Based on the results of TDA, different mathematical models were developed to represent the dynamics between the different severity groups. The best model was the one with the lowest average value of the Akaike Information Criterion for all groups of patients. Our results suggest that different immune mechanisms drive differences between the severity groups. Further inclusion of different components of the immune system will be central for a holistic way of tackling COVID-19. Elsevier Inc. 2023-07 2023-05-05 /pmc/articles/PMC10159681/ /pubmed/37149125 http://dx.doi.org/10.1016/j.mbs.2023.109011 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Research Article Blanco-Rodríguez, Rodolfo Ordoñez-Jiménez, Fernanda Almocera, Alexis Erich S. Chinney-Herrera, Gustavo Hernandez-Vargas, Esteban Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title | Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title_full | Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title_fullStr | Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title_full_unstemmed | Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title_short | Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19 |
title_sort | topological data analysis of antibody dynamics of severe and non-severe patients with covid-19 |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159681/ https://www.ncbi.nlm.nih.gov/pubmed/37149125 http://dx.doi.org/10.1016/j.mbs.2023.109011 |
work_keys_str_mv | AT blancorodriguezrodolfo topologicaldataanalysisofantibodydynamicsofsevereandnonseverepatientswithcovid19 AT ordonezjimenezfernanda topologicaldataanalysisofantibodydynamicsofsevereandnonseverepatientswithcovid19 AT almoceraalexiserichs topologicaldataanalysisofantibodydynamicsofsevereandnonseverepatientswithcovid19 AT chinneyherreragustavo topologicaldataanalysisofantibodydynamicsofsevereandnonseverepatientswithcovid19 AT hernandezvargasesteban topologicaldataanalysisofantibodydynamicsofsevereandnonseverepatientswithcovid19 |